Spectrum Pharmaceuticals, Inc.
SPPI · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 82.3% | – | – | 46.9% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -761.9% | – | – | -683.6% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -772.2% | – | – | -598.7% |
| EPS Diluted | -0.43 | -1.02 | -1.38 | -1.22 |
| % Growth | 57.8% | 26.1% | -13.1% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |